Differential diagnosis between Alzheimer's disease and other dementias: Role of cerebrospinal fluid biomarkers

Clin Biochem. 2019 Oct:72:24-29. doi: 10.1016/j.clinbiochem.2019.04.011. Epub 2019 Apr 15.

Authors

Lucia Farotti¹, Federica Nicoletta Sepe¹, Andrea Toja¹, Roberta Rinaldi¹, Lucilla Parnetti²

Affiliations

¹ Centre for Memory Disturbances, Laboratory of Clinical Neurochemistry, Section of Neurology, Department of Medicine, University of Perugia, Perugia, Italy.
² Centre for Memory Disturbances, Laboratory of Clinical Neurochemistry, Section of Neurology, Department of Medicine, University of Perugia, Perugia, Italy. Electronic address: lucilla.parnetti@unipg.it.

PMID: 30998910
DOI: 10.1016/j.clinbiochem.2019.04.011

No abstract available

Publication types

Review

MeSH terms

Alzheimer Disease / diagnosis*
Amyloid beta-Peptides / cerebrospinal fluid*
Biomarkers / cerebrospinal fluid
Diagnosis, Differential
Humans
Intermediate Filaments / metabolism
Lewy Body Disease / diagnosis
Peptide Fragments / cerebrospinal fluid*
Prognosis
alpha-Synuclein / cerebrospinal fluid*
tau Proteins / cerebrospinal fluid*

Substances

Amyloid beta-Peptides
Biomarkers
Peptide Fragments
SNCA protein, human
alpha-Synuclein
amyloid beta-protein (1-42)
tau Proteins